Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 23 04:00PM ET
253.11
Dollar change
+17.03
Percentage change
7.21
%
IndexS&P 500 P/E39.65 EPS (ttm)6.38 Insider Own8.82% Shs Outstand739.20M Perf Week5.31%
Market Cap187.44B Forward P/E29.11 EPS next Y8.70 Insider Trans-0.05% Shs Float675.23M Perf Month-0.66%
Income4.74B PEG11.66 EPS next Q1.67 Inst Own81.80% Short Float0.94% Perf Quarter9.05%
Sales27.60B P/S6.79 EPS this Y0.80% Inst Trans-0.21% Short Ratio2.37 Perf Half Y22.97%
Book/sh72.36 P/B3.50 EPS next Y13.80% ROA5.69% Short Interest6.35M Perf Year12.95%
Cash/sh7.92 P/C31.96 EPS next 5Y3.40% ROE9.28% 52W Range182.09 - 259.00 Perf YTD9.41%
Dividend Est.0.98 (0.39%) P/FCF32.42 EPS past 5Y11.31% ROI6.67% 52W High-2.27% Beta0.85
Dividend TTM1.05 (0.41%) Quick Ratio1.37 Sales past 5Y8.35% Gross Margin58.66% 52W Low39.00% ATR (14)5.61
Dividend Ex-DateMar 27, 2024 Current Ratio1.68 EPS Y/Y TTM-34.20% Oper. Margin22.01% RSI (14)60.99 Volatility2.16% 1.77%
Employees63000 Debt/Eq0.37 Sales Y/Y TTM-12.29% Profit Margin17.18% Recom1.65 Target Price269.29
Option/ShortYes / Yes LT Debt/Eq0.33 EPS Q/Q-51.20% Payout16.45% Rel Volume2.57 Prev Close236.08
Sales Surprise3.09% EPS Surprise11.84% Sales Q/Q-23.47% EarningsApr 23 BMO Avg Volume2.68M Price253.11
SMA203.94% SMA501.85% SMA20011.04% Trades Volume6,875,952 Change7.21%
Date Action Analyst Rating Change Price Target Change
Apr-17-24Upgrade HSBC Securities Hold → Buy $280
Jan-24-24Downgrade Barclays Overweight → Equal Weight $240
Dec-18-23Initiated HSBC Securities Hold
Dec-13-23Resumed Wolfe Research Peer Perform
Dec-07-23Downgrade Goldman Buy → Neutral $215 → $205
Jul-19-23Initiated Raymond James Outperform $270
May-01-23Initiated SVB Securities Outperform $300
Apr-26-23Downgrade BofA Securities Buy → Neutral $310 → $250
Apr-18-23Upgrade Wells Fargo Equal Weight → Overweight $275 → $285
Jan-05-23Downgrade Credit Suisse Outperform → Neutral $315 → $300
Today 04:41PM
12:21PM
12:07PM
11:39AM
11:33AM
11:29AM Loading…
11:29AM
10:53AM
10:44AM
09:30AM
07:31AM
07:10AM
06:59AM
06:55AM
06:26AM
06:07AM
06:00AM Loading…
06:00AM
05:37AM
Apr-19-24 09:52AM
Apr-18-24 04:27PM
12:10PM
10:58AM
09:15AM
Apr-17-24 08:00AM
Apr-13-24 12:16PM
Apr-12-24 12:30PM
Apr-11-24 04:30PM
12:19PM
Apr-05-24 06:00PM
Apr-04-24 09:00AM
08:00AM
06:15PM Loading…
Apr-02-24 06:15PM
Mar-28-24 03:41AM
Mar-27-24 06:00PM
09:30AM
08:00AM
Mar-26-24 06:15PM
Mar-21-24 04:15PM
10:25AM
09:00AM
Mar-20-24 06:00PM
08:00AM
Mar-18-24 06:15PM
Mar-13-24 10:23AM
08:05AM
Mar-12-24 06:00PM
Mar-11-24 06:15PM
Mar-06-24 06:00AM
Mar-05-24 06:00PM
Mar-04-24 09:06AM
Mar-02-24 10:42AM
Mar-01-24 09:00AM
Feb-29-24 11:30AM
Feb-28-24 06:00PM
Feb-27-24 04:15PM
Feb-25-24 02:38PM
Feb-22-24 09:01PM
04:15PM
Feb-21-24 04:15PM
Feb-17-24 01:28PM
Feb-12-24 03:03PM
Feb-09-24 01:40AM
Feb-05-24 07:30AM
Feb-01-24 11:08AM
Jan-30-24 11:14PM
01:26PM
11:44AM
11:08AM
09:30AM
07:10AM
06:34AM
06:17AM
06:00AM
Jan-29-24 12:56PM
08:36AM
07:30AM
Jan-26-24 08:10AM
Jan-25-24 09:15AM
Jan-23-24 10:00AM
Jan-22-24 06:00PM
Jan-19-24 04:27AM
Jan-17-24 12:10PM
Jan-16-24 06:15PM
Jan-10-24 06:00PM
Jan-09-24 06:15PM
09:19AM
07:30AM
Jan-08-24 04:15PM
Jan-03-24 06:00PM
Jan-02-24 06:15PM
05:00PM
Dec-27-23 06:15PM
Dec-25-23 08:14PM
Dec-21-23 04:30PM
09:28AM
Dec-19-23 10:56AM
Dec-18-23 06:00PM
04:43AM
Dec-14-23 05:40AM
Dec-13-23 08:12PM
04:06PM
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Raskas DanielSVP - Corporate DevelopmentFeb 26 '24Option Exercise58.4823,7571,389,30961,859Feb 27 05:01 PM
Raskas DanielSVP - Corporate DevelopmentFeb 26 '24Sale252.0023,7575,986,76438,102Feb 27 05:01 PM
LOHR WALTER GDirectorFeb 15 '24Option Exercise52.563,289172,87017,418Feb 16 05:01 PM
LOHR WALTER GDirectorFeb 15 '24Sale251.153,289826,03214,129Feb 16 05:01 PM
Couchara GeorgeannSVP, Human ResourcesFeb 13 '24Option Exercise70.712,622185,4146,022Feb 14 05:00 PM
Couchara GeorgeannSVP, Human ResourcesFeb 13 '24Sale242.672,622636,2904,244Feb 14 05:00 PM
List TeriDirectorFeb 06 '24Option Exercise52.563,289172,87023,015Feb 08 05:00 PM
List TeriDirectorFeb 06 '24Sale248.323,289816,72419,726Feb 08 05:00 PM
Gutierrez-Ramos Jose-CarlosSVP, Chief Science OfficerAug 21 '23Sale250.54590147,8196,939Aug 22 05:00 PM
Raskas DanielSVP - Corporate DevelopmentJul 28 '23Option Exercise56.7011,213635,77749,501Aug 01 05:03 PM
Zerhouni Elias A.DirectorJul 28 '23Option Exercise50.803,490177,29230,523Aug 01 05:02 PM
SCHWIETERS JOHN TDirectorJul 28 '23Option Exercise50.803,490177,29222,583Aug 01 05:02 PM
FILLER LINDADirectorJul 28 '23Option Exercise59.172,922172,89541,074Aug 01 05:00 PM
Raskas DanielSVP - Corporate DevelopmentJul 28 '23Sale260.6511,2132,922,65238,288Aug 01 05:03 PM
FILLER LINDADirectorJul 28 '23Sale260.2510,1902,651,97838,152Aug 01 05:00 PM
Weidemanis JoakimExecutive Vice PresidentJul 26 '23Option Exercise56.7022,4391,272,291111,128Jul 27 05:01 PM
List TeriDirectorJul 26 '23Option Exercise50.803,490177,29220,984Jul 27 05:00 PM
Weidemanis JoakimExecutive Vice PresidentJul 26 '23Sale263.4222,4395,910,83288,689Jul 27 05:01 PM
List TeriDirectorJul 26 '23Sale263.303,490918,91717,494Jul 27 05:00 PM
Raskas DanielSVP - Corporate DevelopmentMay 31 '23Option Exercise57.9019,8471,149,14158,520Jun 01 05:00 PM
Raskas DanielSVP - Corporate DevelopmentMay 31 '23Sale228.5019,8474,535,04038,673Jun 01 05:00 PM
LOHR WALTER GDirectorMay 05 '23Option Exercise50.803,490177,29215,605May 08 05:08 PM
LOHR WALTER GDirectorMay 05 '23Sale240.883,490840,68512,115May 08 05:08 PM
Weidemanis JoakimExecutive Vice PresidentMay 04 '23Option Exercise57.909,934575,179101,357May 05 05:01 PM
Weidemanis JoakimExecutive Vice PresidentMay 04 '23Sale245.279,9342,436,51291,423May 05 05:01 PM
Couchara GeorgeannSVP, Human ResourcesMay 04 '23Sale245.27695170,4631,565May 05 05:00 PM
Gutierrez-Ramos Jose-CarlosSVP, Chief Science OfficerMay 01 '23Sale242.19500121,0967,529May 02 05:01 PM